SL Science Holding Limited - Ordinary Shares (SLBT)
3.2900
+0.6500 (24.62%)
NASDAQ· Last Trade: Aug 3rd, 7:39 PM EDT
Detailed Quote
| Previous Close | 2.640 |
|---|---|
| Open | 2.610 |
| Bid | 3.150 |
| Ask | 3.210 |
| Day's Range | 2.610 - 3.398 |
| 52 Week Range | 2.537 - 14.50 |
| Volume | 198,501 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 104,073 |
Chart
News & Press Releases
Gainers Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday's regular session. The market value of their outstanding shares is at $2.0 million. SL Science Holding (NASDAQ:SLBT)
Via Benzinga · August 3, 2026
Taipei, TAIWAN, June 18, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced its financial results for the full year ended December 31, 2025.
By SL Science Holding Limited · Via GlobeNewswire · June 18, 2026